DexCom, Inc. (DXCM) stock analysis

In our weekly check, DexCom, Inc. is graded B (A to F). Of 24 checks on debt, profit, cash flow and trend: 19 pass, warnings: 3, red flags: 2.

About DexCom, Inc.

DexCom, Inc. is a Healthcare company (Medical Devices) based in the United States, listed on NASDAQ as DXCM.

What our checks show for DXCM

Red flags

Warning signs

Strengths

Next earnings report: 2027-02-11

Similar companies

GEHC · ZBH · EW · BSX · GKOS · SNN

Questions

What grade does DexCom, Inc. (DXCM) have?

In our weekly check, DexCom, Inc. is graded B (A to F). Of 24 checks on debt, profit, cash flow and trend: 19 pass, warnings: 3, red flags: 2. The grade is a risk check, not a buy or sell recommendation.

What are the main risks of DXCM stock?

This week's biggest flags for DexCom, Inc.: Gross margin falling, Deep past fall, Very volatile. In total 5 of 24 checks show a warning or a red flag.

What does DexCom, Inc. do?

DexCom, Inc. is a Healthcare company (Medical Devices) based in the United States, listed on NASDAQ as DXCM.

When does DexCom, Inc. report earnings next?

The next earnings report is expected on 2027-02-11. We re-run the checks every week, so the grade can change after it.

The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.

Updated 2026-11-14

Open the full analysis